Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

SCAI slides: Resolute at 3 years in patients with diabetes

Kimberly A. Skelding, MD, of Geisinger Medical Center in Danville, Pa., presented three-year results of patients with diabetes mellitus who were enrolled in the Resolute U.S. trial at the Society of Cardiovascular Angiography and Interventions (SCAI) scientific sessions in Orlando, Fla. 

Edwards Lifesciences announces CFO retirement

Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced that Thomas M. Abate, the company's chief financial officer, plans to retire later this year. Abate, who turns 60 in August, plans to remain CFO until his successor is in place. The company has retained Peter Crist of Crist/Kolder Associates to assist in the CFO search.

Ranbaxy pays $500M to settle adulterated drugs suit

Ranbaxy has agreed to pay $500 million to settle a whistleblower lawsuit that claimed the pharmaceutical manufacturer made and distributed adulterated drugs at two facilities in India. The payment includes $350 million as a civil settlement plus $150 million in criminal fines. 

The Heart Rhythm Society announces Dr. Hugh Calkins as the organization’s 35th president

Hugh Calkins, MD, FHRS, CCDS, was named the president of the Heart Rhythm Society (HRS) during the 34th Annual Scientific Sessions, held in Denver last week.  Announced during the Presidents’ Reception on Friday, May 10th, Dr. Calkins now serves as the 35th president of HRS, making Anne M. Gillis, MD, FHRS, the immediate past president. Dr. Calkins is currently a Nicholas J. Fortuin Professor of Cardiology and Professor of Medicine at the Johns Hopkins University School of Medicine in Baltimore, Maryland.  

FDA approves CRM monitoring system

The FDA approved Smartview technology to remotely monitor patients with implanted cardiac rhythm management (CRM) devices. The system allows patients to transmit data electronically from implanted cardiac devices to their physicians. 

St. Jude’s ICDs, CRT-Ds get CE mark

The Ellipse and Assura portfolio of implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy-defibrillators (CRT-Ds) received CE mark in Europe, St. Jude Medical announced.

Using sophisticated techniques to study congenital heart disease

Richard Lifton, MD, PhD, chair of the genetics department at Yale University, and Jonathan R. Kaltman, MD, chief of the Heart Development and Structural Diseases Branch at the National Heart, Lung, and Blood Institute, discuss genetic causes of heart disease in a video.  Findings from the research team’s large-scale sequencing analysis of congenital heart disease were published online May 12 in Nature. 

American Heart Association and Macy's announce Multicultural Scholarship recipients

The American Heart Association and Macy’s have awarded 16 scholarships of $2,500 each to increase culturally-sensitive, patient-centered care.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.